Patient Blood Mangement (PBM) Using IV Iron in Patients With Gynecologic Cancer

NANot yet recruitingINTERVENTIONAL

Enrollment

334

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions

Gynecologic Cancer

Interventions

DRUG

Ferric Carboxymaltose 50Mg/Ml Inj 20Ml

ferric carboxymaltose 1000mg, fixed dose for intervention group

DRUG

RBC

pack RBC transfusion

Trial Locations (1)

Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul